DLBCL
Phase 2 Terminated
5 enrolled 5 charts
Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
Phase 2 Terminated
46 enrolled 5 charts
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
Phase 1 Terminated
4 enrolled 8 charts
Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
Phase 2 Terminated
3 enrolled 7 charts
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Phase 2 Terminated
7 enrolled 9 charts
Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
Phase 1 Terminated
22 enrolled
Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood
Phase 3 Terminated
400 enrolled